Literature DB >> 16926160

The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake.

Irene Brunk1, Christian Blex, Sivaramakrishna Rachakonda, Markus Höltje, Sandra Winter, Ingrid Pahner, Diego J Walther, Gudrun Ahnert-Hilger.   

Abstract

The activity of vesicular monoamine transporters (VMATs) is down-regulated by the G-protein alpha-subunits of G(o2) and G(q), but the signaling pathways are not known. We show here that no such regulation is observed when VMAT1 or VMAT2 are expressed in Chinese hamster ovary (CHO) cells. However, when the intracellular compartments of VMAT-expressing CHO cells are preloaded with different monoamines, transport becomes susceptible to G-protein-dependent regulation, with differences between the two transporter isoforms. Epinephrine induces G-protein-mediated inhibition of transmitter uptake in CHOVMAT1 cells but prevents inhibition induced by dopamine in CHOVMAT2 cells. Epinephrine also antagonizes G-protein-mediated inhibition of monoamine uptake by VMAT2 expressing platelets or synaptic vesicles. In CHOVMAT2 cells G-protein-mediated inhibition of monoamine uptake can be induced by 5-hydroxytryptamine (serotonin) 1B receptor agonists, whereas alpha1 receptor agonists modulate uptake into CHOVMAT1 cells. Accordingly, 5-hydroxytryptamine 1B receptor antagonists prevent G-protein-mediated inhibition of uptake in partially filled platelets and synaptic vesicles expressing VMAT2. CHO cells expressing VMAT mutants with a shortened first vesicular loop transport monoamines. However, no or a reduced G-protein regulation of uptake can be initiated. In conclusion, vesicular content is involved in the activation of vesicle associated G-proteins via a structure sensing the luminal monoamine content. The first luminal loop of VMATs may represent a G-protein-coupled receptor that adapts vesicular filling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926160     DOI: 10.1074/jbc.M603204200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

3.  Synaptic and vesicular coexistence of VGLUT and VGAT in selected excitatory and inhibitory synapses.

Authors:  Johannes-Friedrich Zander; Agnieszka Münster-Wandowski; Irene Brunk; Ingrid Pahner; Gisela Gómez-Lira; Uwe Heinemann; Rafael Gutiérrez; Gregor Laube; Gudrun Ahnert-Hilger
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

Review 4.  Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels.

Authors:  Charles P Mercado; Fusun Kilic
Journal:  Mol Interv       Date:  2010-08

5.  Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Authors:  Irene Brunk; Christian Blex; Carles Sanchis-Segura; Jan Sternberg; Stephanie Perreau-Lenz; Ainhoa Bilbao; Heide Hörtnagl; Jens Baron; Judyta Juranek; Gregor Laube; Lutz Birnbaumer; Rainer Spanagel; Gudrun Ahnert-Hilger
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

Review 6.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

7.  Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.

Authors:  Endrit Ziu; Charles P Mercado; Yicong Li; Preeti Singh; Billow A Ahmed; Samuel Freyaldenhoven; Shelly Lensing; Jerry Ware; Fusun Kilic
Journal:  J Mol Cell Cardiol       Date:  2012-02-15       Impact factor: 5.000

8.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

9.  VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Authors:  P K Multani; R Hodge; M A Estévez; T Abel; H Kung; M Alter; B Brookshire; I Lucki; A H Nall; K Talbot; G A Doyle; F W Lohoff
Journal:  Neuroscience       Date:  2012-11-29       Impact factor: 3.590

Review 10.  VMAT2 gene expression and function as it applies to imaging beta-cell mass.

Authors:  Paul E Harris; Caterina Ferrara; Pasquale Barba; Teresa Polito; Matthew Freeby; Antonella Maffei
Journal:  J Mol Med (Berl)       Date:  2007-07-31       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.